Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced the publication of "Characterization of plasma cell-free DNA variants as of ...

Samsara Inc. ("Samsara") , the pioneer of the Connected Operations® Cloud, today announced the release of its State of Connected Operations Report: Building for the Next Generation: Workforce Trends ...

Tick-borne encephalitis virus (TBEV) has now been confirmed in locally acquired human cases in the U.K., with evidence of ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

TD Cowen downgraded Illumina Inc (NASDAQ:ILMN) to "Hold" following the company's fourth-quarter earnings, citing weaker-than-expected next-generation sequencing (NGS) consumable growth, increasing ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

Alliance Global Partners initiated coverage of Quantum-Si (QSI) with a Buy rating and $3.75 price target Connecticut-based Quantum-Si develops ...

Next-generation sequencing tests offer potential for more precise remission determination, but technical and financial barriers exist. Cost-effectiveness and payer acceptance are essential for ...